URLO
URLO
valia.be
Valia

Dans la même catégorie

/ycompany.be EN DIRECT
Y Company
Voir en direct ↗
Y
Y Company
ycompany.be • ★ 5.0

Independent Belgian corporate affairs and public affairs agency. Expertise in stakeholder relations, EU policy, and strategic communications for…

Visiter →
/publicea.be EN DIRECT
Publicea
Voir en direct ↗
P
Publicea
publicea.be • ★ 5.0

Brussels-based consultancy specialising in governmental affairs, regulatory support and stakeholder engagement at European, federal and regional levels.

Visiter →
/phrase-consulting.be EN DIRECT
PhRAse Consulting
Voir en direct ↗
P
PhRAse Consulting
phrase-consulting.be • ★ 5.0

PhRAse offers pharmaceutical regulatory affairs consulting and on-site support in Leuven, Belgium. Expert guidance for regulatory compliance.

Visiter →
/voicing.be EN DIRECT
Voicing
Voir en direct ↗
V
Voicing
voicing.be • ★ 5.0

Voicing provides contextual intelligence for EU public affairs teams: identifies stakeholders, maps arguments, and informs strategic outreach with public…

Visiter →
/euraxis.be EN DIRECT
Euraxis
Voir en direct ↗
E
Euraxis
euraxis.be • ★ 5.0

Brussels-based firm monitoring EU institutions and legislation. Weekly updates, legislative trackers, and policy analysis for regulatory professionals.

Visiter →
/phara-plus.be EN DIRECT
PhaRA
Voir en direct ↗
P
PhaRA
phara-plus.be • ★ 5.0

PhaRA specializes in global regulatory affairs consulting. Strategic partnership and in-depth expertise for pharmaceutical and life sciences companies…

Visiter →
/ampersandpartners.be EN DIRECT
Ampersand Partners
Voir en direct ↗
A
Ampersand Partners
ampersandpartners.be • ★ 5.0

Ampersand Partners advises C-level executives and corporate leaders on public affairs, regulatory strategy, and policy risk mitigation across multiple…

Visiter →
/rlmconsulting.be EN DIRECT
RLM Consulting
Voir en direct ↗
R
RLM Consulting
rlmconsulting.be • ★ 0.0

RLM Consulting provides regulatory strategy and operational support for bio-pharma companies throughout medicinal product development, from preclinical to…

Visiter →